Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
36.65USD
19 Aug 2019
36.65USD
19 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$36.65
$36.65
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
150,114
150,114
52-wk High
$42.91
$42.91
52-wk Low
$18.56
$18.56
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Jun '19 | 25.00 | -0.562 |
| Mar '19 | 0.00 | -1.245 | |
| FY 2018 | Dec '18 | 0.00 | -0.857 |
| Sep '18 | 0.00 | -0.649 | |
| Jun '18 | 0.00 | -0.646 | |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 8 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-19 | 9 | 0.56 | 5.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 9 | 25.56 | 30.00 | 25.00 | 21.88 |
| Year Ending Dec-20 | 10 | 17.97 | 104.00 | 1.00 | 14.20 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 10 | -1.18 | -1.03 | -1.37 | -0.75 |
| Quarter Ending Dec-19 | 10 | -1.19 | -1.03 | -1.49 | -0.80 |
| Year Ending Dec-19 | 10 | -4.20 | -3.52 | -4.83 | -2.68 |
| Year Ending Dec-20 | 10 | -4.59 | -2.54 | -5.64 | -3.33 |
| LT Growth Rate (%) | 1 | 23.18 | 23.18 | 23.18 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.38 | 32.67 | |
| P/E High - Last 5 Yrs. | -- | 147.67 | 47.29 | |
| P/E Low - Last 5 Yrs. | -- | 47.98 | 23.87 | |
| Beta | -- | 1.09 | 0.89 | |
| Price to Sales (TTM) | -- | 49.45 | 7.91 | |
| Price to Book (MRQ) | -- | 10.14 | 5.38 | |
| Price to Tangible Book (MRQ) | 8.04 | 13.74 | 6.71 | |
| Price to Cash Flow (TTM) | -- | 55.94 | 24.37 | |
| % Owned Institutions | -- | 3.66 | 1.45 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.38 | |
| Dividend 5 Year Growth Rate | -- | 0.78 | 4.54 | |
| Payout Ratio(TTM) | -- | 7.01 | 40.24 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 205.61 | 12.23 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 49.06 | 7.74 | |
| Sales - 5 Yr. Growth Rate | -- | 22.79 | 10.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 75.23 | 42.99 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.92 | 10.32 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.20 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.23 | 2.21 |
| Current Ratio (MRQ) | 11.53 | 3.59 | 3.03 |
| LT Debt to Equity (MRQ) | 1.59 | 18.57 | 10.20 |
| Total Debt to Equity (MRQ) | 1.80 | 31.18 | 14.55 |
| Interest Coverage (TTM) | -- | -44.60 | 29.80 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.08 | 52.25 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.28 | 50.41 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.38 | 13.13 | |
| Operating Margin (TTM) | -- | -184.16 | 6.92 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.82 | 8.94 | |
| Pre-Tax Margin (TTM) | -- | -174.91 | 6.13 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.58 | 9.23 | |
| Net Profit Margin (TTM) | -- | -181.60 | 2.76 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -136.95 | 5.60 | |
| Effective Tax Rate (TTM) | -- | 22.42 | 22.40 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.43 | 22.74 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,668,825 | 887,145,970 | |
| Net Income/Employee (TTM) | -- | 533,853 | 101,828,577 | |
| Receivable Turnover (TTM) | -- | 6.28 | 5.93 | |
| Inventory Turnover (TTM) | -- | 1.88 | 3.36 | |
| Asset Turnover (TTM) | -- | 0.32 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 6.40 | 11.17 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.49 | 12.34 | |
| Return on Investment (TTM) | -- | 8.94 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.81 | 16.02 | |
| Return on Equity (TTM) | -- | 10.07 | 15.78 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.38 | 17.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -30.90 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -- | -- | -- | 99 |
| 13 Week | -- | -- | -- | 95 |
| 26 Week | -- | -- | -- | 97 |
| 52 Week | -- | -- | -- | 71 |
| YTD | -- | -- | -- | 73 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 62.36% |
| # of Holders: | 128 |
| Total Shares Held: | 23,829,518 |
| 3 Mo. Net Change: | 537,180 |
| # New Positions: | 21 |
| # Closed Positions: | 14 |
| # Increased Positions: | 69 |
| # Reduced Positions: | 41 |
| # Net Buyers: | 28 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.